Safety and efficacy of therapeutic cannabis in fibromyalgia (STUDY 2019)

  • Safety and efficacy of therapeutic cannabis in fibromyalgia (STUDY 2019)

Effective and effective treatment of fibromyalgia (chronic pain) is still a mystery to mankind. But cannabis could be the solution.


Extract from the study

Chronic pain can be treated with medical cannabis. However, there is still insufficient evidence available to support the use of therapeutic cannabis in the treatment of fibromyalgia. The aim of this study was to investigate the characteristics, safety and efficacy of therapeutic cannabis.

Method used:
During the study, fibromyalgia patients were observed every six months and agreed to complete a questionnaire at a specialized clinic. These observations were carried out during 2015 to 2017.

Results:
A total of 367 people participated in the research, of which 301 were women. The average age was 52.9 years. 28 patients (7.6%) discontinued their treatment within six months of initiating the study. Pain intensity (scale from 0 to 10) decreased from 9 to 5. On average, 70.8% of people experienced some treatment-related outcome after six months.

According to various analyzes, research results are influenced by age over 60, concerns about cannabis treatment, spasticity and previous cannabis use. The most common side effects were malaise (7.9%), dry mouth (6.7%) and problems with the digestive system (5.4%). However, all effects were very weak.

Conclusion:
Medical cannabis appears to be a safe and effective alternative medicine for the treatment of fibromyalgia and its symptoms. Therefore, standardization of drug compounds is recommended.


Key words: therapeutic cannabis, fibromyalgia, quality of life, chronic pain


Authors: Iftach Sagy, Mahmoud Abu-Shakra, Lihi Bar-Lev Schleider, Victor Novack
You can read more of this study at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616435/. The whole study is in English.

Photo source: pixabay.com (author: geralt)